title: Pro- and anti-angiogenic agents.
abstract: The vascular endothelium has been characterized in every organ system, and is described as a selective permeable barrier and as a dynamic and disseminated organ with endocrine function. These activities have been shown to result from the interactions of ligands with membrane-bound receptors as well as through specific junctional proteins and receptors that govern cell-cell interactions. The endothelial cells' movement (e.g., angiogenesis) has been hypothesized to occur following the release of stimuli that could promote the formation of new blood vessels. Angiogenesis has also been reported to be the continued expansion of the vascular tree in avascular regions, as a result of the sprouting of endothelial cells from existing vessels. Most commonly, angiogenesis has been characterized during wound healing and tumour growth. Herein we summarize and discuss the latest results from fundamental laboratory research aimed at proving a link between the proliferation of cancer and angiogenesis, as well as the new rationale around novel pro- and anti-angiogenic molecules.
authors.affiliation: Biomnis Laboratories R&D, 78, avenue de Verdun, 94200 Ivry-sur-Seine, France.
authors.forename: A
authors.initials: A
authors.lastname: Bridoux
authors.forename: S A
authors.initials: SA
authors.lastname: Mousa
authors.forename: M-M
authors.initials: MM
authors.lastname: Samama
mesh_terms: D043925:Angiogenesis Inducing Agents / Q000627:therapeutic use*; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy
chemical_list: D043925:Angiogenesis Inducing Agents; D020533:Angiogenesis Inhibitors